PPI-amoxicillin dual therapy for Helicobacter pylori infection: An update based on a systematic review and meta-analysis.

Cai-Ping GaoDi ZhangTing ZhangJin-Xia WangSheng-Xi HanDavid Yates Graham Hong Lu

Published in: Helicobacter (2020)

Compared with the current mainstream guidelines-recommended therapies, PPI-amoxicillin dual therapy has the same efficacy and compliance, and generally PPI-amoxicillin dual therapy causes fewer side effects.

Keyphrases

helicobacter pylori infection
protein protein
helicobacter pylori
small molecule
stem cells